Columbia Sportswear COO sells 6,857 shares

Q: How many COLM shares did Lisa Kulok sell, and at what price?

Lisa Kulok sold 6,857 common shares at $68.475 per share on November 2, 2026. No Rule 10b5-1 plan is reported.

Q: How many COLM options did Lisa Kulok exercise?

Lisa Kulok exercised options for 6,857 shares on November 2, 2026, at an exercise price of $55.53 per share. The exercise resulted in the acquisition of 6,857 common shares.

Q: When did Lisa Kulok's options become exercisable?

The options were granted for 9,143 shares on January 26, 2017. They became exercisable for 25% of the shares on each of the first four anniversaries of the grant date.

The options stemmed from a 2017 grant for 9,143 shares, with 25% becoming exercisable on each of the first four anniversaries.

Available on EDGAR 11/04/2026 - 07:58 PM EST Accepted by SEC EDGAR 11/04/2026 - 07:58 PM EST

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Columbia Sportswear (COLM) EVP, COO Lisa Kulok exercised options for 6,857 shares on November 2, 2026, at an exercise price of $55.53 per share, acquired 6,857 common shares through the exercise, and sold 6,857 common shares at $68.475 per share that day. The option position was reported as zero after exercise. No Rule 10b5-1 plan is reported. The options had been granted for 9,143 shares on January 26, 2017; 25% became exercisable on each of the first four anniversaries of the grant date.

Insider Trade Summary

Exercise and Sale: 6,857 shares ($89K approx. pre-tax spread)

Exercise and Sale 3 txns

Insider Kulok Lisa

Role EVP, COO

Sold 6,857 shs ($470K)

Approx. gross sale proceeds $470K

Approx. exercise cost $381K

Approx. pre-tax spread $89K

Type	Security	Shares	Price	Value
Exercise	Employee Stock Option (right to buy) ^F1	6,857	$0.00	$0.00
Exercise	Common Stock	6,857	$55.53	$381K
Sale	Common Stock	6,857	$68.475	$470K

Holdings After Transaction: Employee Stock Option (right to buy) — 0 contracts (Direct); Common Stock — 8,180 shares (Direct)

Footnotes (1)

F1. The option was granted for 9,143 shares on January 26, 2017 and became exercisable for 25% of the shares on each of the first four anniversaries of the grant date.

Key Figures

Options exercised: 6,857 options Exercise price: $55.53 per share Common shares acquired: 6,857 shares +5 more

8 metrics

Options exercised 6,857 options November 2, 2026

Exercise price $55.53 per share Options exercised November 2, 2026

Common shares acquired 6,857 shares Through option exercise on November 2, 2026

Common shares sold 6,857 shares November 2, 2026

Sale price $68.475 per share Common shares sold November 2, 2026

Options following exercise 0 options Reported after the November 2, 2026 exercise

Original option grant 9,143 shares Granted January 26, 2017

Annual exercisability 25% On each of the first four anniversaries of the grant date

Key Terms

Employee Stock Option, exercisable, grant date

3 terms

Employee Stock Option technical

"Employee Stock Option (right to buy)"

An employee stock option is a promise that lets a worker buy company shares later at a predetermined price, often after they stay for a certain period or meet performance goals — think of it like a coupon that locks in today's price for a future purchase. It matters to investors because options align employees’ incentives with company performance, can increase the number of shares outstanding (dilution) when exercised, and represent a compensation cost that affects reported profits and shareholder value.

exercisable technical

"became exercisable for 25% of the shares"

grant date technical

"anniversaries of the grant date"

The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many COLM shares did Lisa Kulok sell, and at what price?

Lisa Kulok sold 6,857 common shares at $68.475 per share on November 2, 2026. No Rule 10b5-1 plan is reported.

How many COLM options did Lisa Kulok exercise?

Lisa Kulok exercised options for 6,857 shares on November 2, 2026, at an exercise price of $55.53 per share. The exercise resulted in the acquisition of 6,857 common shares.

When did Lisa Kulok's options become exercisable?

The options were granted for 9,143 shares on January 26, 2017. They became exercisable for 25% of the shares on each of the first four anniversaries of the grant date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kulok Lisa

(Last)

(First)

(Middle)

C/O COLUMBIA SPORTSWEAR COMPANY

14375 NW SCIENCE PARK DRIVE

(Street)

PORTLAND

OREGON

97229

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
COLUMBIA SPORTSWEAR CO [ COLM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EVP, COO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	11/02/2026		M		6,857	A	$55.53	15,037	D
Common Stock	11/02/2026		S		6,857	D	$68.475	8,180	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Employee Stock Option (right to buy)	$55.53	11/02/2026		M			6,857	⁽¹⁾	01/25/2027	Common Stock	6,857	$0	0	D

Explanation of Responses:

1. The option was granted for 9,143 shares on January 26, 2017 and became exercisable for 25% of the shares on each of the first four anniversaries of the grant date.

Remarks:

	Christina A. Mecklenborg, Attorney-in-Fact	11/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR